WEEKLY BORTEZOMIB FOR THE TREATMENT OF STEROID REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)

被引：1
|
作者：
Miller, A. M. [1 ]
Schneider, R. [1 ]
Agura, E. A. [1 ]
Vance, E. [1 ]
Bergman, R. B. [1 ]
Fay, J. [1 ]
Pineiro, L. [1 ]
Powell, S. [1 ]
Ovcina, Tadic M. [1 ]
Sampson, C. A. [1 ]
机构：
[1] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.567
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
530
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [1] Treatment of chronic graft-versus-host disease with bortezomib
    Pai, Chien-Chun Steven
    Chen, Mingyi
    Mirsoian, Annie
    Grossenbacher, Steven K.
    Tellez, Joseph
    Ames, Erik
    Sun, Kai
    Jagdeo, Jared
    Blazar, Bruce R.
    Murphy, William J.
    Abedi, Mehrdad
    BLOOD, 2014, 124 (10) : 1677 - 1688
  • [2] Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
    Panayotis Kaloyannidis
    Eshrak Al Shaibani
    Ioannis Apostolidis
    Solaf Kanfar
    Khalid Al Anezi
    Hani Al Hashmi
    Bone Marrow Transplantation, 2019, 54 : 746 - 748
  • [3] Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
    Kaloyannidis, Panayotis
    Al Shaibani, Eshrak
    Apostolidis, Ioannis
    Kanfar, Solaf
    Al Anezi, Khalid
    Al Hashmi, Hani
    BONE MARROW TRANSPLANTATION, 2019, 54 (05) : 746 - 748
  • [4] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
    Trenschel, R
    Trampenau, C
    Ditschkowski, M
    Elmaagacli, A
    Ottinger, H
    Steckel, N
    Biersack, H
    Peceny, R
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
  • [5] Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease
    Belina, Morgan E.
    Driscoll, Timothy A.
    Blanchard, Sarah K.
    Cardones, Adela R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (03) : 432 - 433
  • [6] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [7] Ruxolitinib for Treatment of Steroid Refractory Sclerotic Chronic Graft-Versus-Host Disease (cGVHD): Results of a Multicenter Phase II Trial
    Bhatt, Vijaya Raj
    Shostrom, Valerie K.
    Saad, Ayman
    Hamilton, Betty K.
    Gundabolu, Krishna
    Maness, Lori
    Kumar, Virender
    Mahato, Ram, I
    Smith, Lynette M.
    Nishihori, Taiga
    Lee, Stephanie J.
    BLOOD, 2022, 140 : 1379 - 1380
  • [8] Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
    Drobyski, William R.
    Pasquini, Marcelo
    Kovatovic, Kathy
    Palmer, Jeanne
    Rizzo, J. Douglas
    Saad, Ayman
    Saber, Wael
    Hari, Parameswaran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) : 1862 - 1868
  • [9] Infliximab as treatment for steroid refractory acute and chronic graft-versus-host disease.
    Trenschel, R
    Ditschkowski, M
    Biersack, H
    Trampenau, C
    Steckel, NK
    Peceny, R
    Ottinger, H
    Elmaagacli, A
    Scheulen, ME
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 100 (11) : 450B - 450B
  • [10] Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease
    Ilhan, O
    Arat, M
    Arslan, Ö
    Ayyildiz, E
    Sanli, H
    Beksac, M
    Özcan, M
    Gürman, G
    Akan, H
    TRANSFUSION AND APHERESIS SCIENCE, 2004, 30 (03) : 185 - 187
12345